SVB Leerink Downgrades Agios Pharma (AGIO) to Market Perform

February 26, 2021 6:33 AM EST Send to a Friend
SVB Leerink analyst Andrew Berens downgraded Agios Pharma (NASDAQ: AGIO) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login